Zizhao Guo

Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Correction: Trends, survival and regional control of sentinel lymph node biopsy versus axillary dissection in cN0 breast cancer: a multicenter cohort in China.

Correction: Trends, survival and regional control of sentinel lymph node biopsy versus axillary dissection in cN0 breast cancer: a multicenter cohort in China.

Journal: Frontiers in oncology

Published: June 25, 2026

Trends, survival and regional control of sentinel lymph node biopsy versus axillary dissection in cN0 breast cancer: a multicenter cohort in China.

Trends, survival and regional control of sentinel lymph node biopsy versus axillary dissection in cN0 breast cancer: a multicenter cohort in China.

Journal: Frontiers in oncology

Published: February 11, 2026

ASO Visual Abstract: Analysis of the Current Status of de Novo Metastatic Breast Cancer Surgery in China and the United States: A Multicenter Real-World Study.

ASO Visual Abstract: Analysis of the Current Status of de Novo Metastatic Breast Cancer Surgery in China and the United States: A Multicenter Real-World Study.

Journal: Annals of surgical oncology

Published: December 16, 2025

Clinical application of PARP inhibitors and emerging strategies to overcome resistance: a pan-cancer perspective.

Clinical application of PARP inhibitors and emerging strategies to overcome resistance: a pan-cancer perspective.

Journal: Biomarker research

Published: November 13, 2025

Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.

Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.

Journal: Mediators of inflammation

Published: October 29, 2025

Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.

Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.

Journal: Mediators of inflammation

Published: October 29, 2025

Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.

Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.

Journal: Mediators of inflammation

Published: October 29, 2025

ASO Author Reflections: Analysis of the Current Status of De Novo Metastatic Breast Cancer Surgery in China and the United States: A Multicenter Real-World Study.

ASO Author Reflections: Analysis of the Current Status of De Novo Metastatic Breast Cancer Surgery in China and the United States: A Multicenter Real-World Study.

Journal: Annals of surgical oncology

Published: October 09, 2025

Comment on: "Elastography-based AI model can predict axillary status after neoadjuvant chemotherapy in breast cancer with nodal involvement".

Comment on: "Elastography-based AI model can predict axillary status after neoadjuvant chemotherapy in breast cancer with nodal involvement".

Journal: International journal of surgery (London, England)

Published: June 26, 2025

Analysis of the Current Status of De Novo Metastatic Breast Cancer Surgery in China and the USA: A Multicenter Real-World Study.

Analysis of the Current Status of De Novo Metastatic Breast Cancer Surgery in China and the USA: A Multicenter Real-World Study.

Journal: Annals of surgical oncology

Published: June 03, 2025

Multiple Equine Therapies for the Treatment of Gross Motor Function in Children with Cerebral Palsy: A Systematic Review.

Multiple Equine Therapies for the Treatment of Gross Motor Function in Children with Cerebral Palsy: A Systematic Review.

Journal: Journal of community health nursing

Published: January 17, 2024

Hsa_circYARS interacts with miR-29a-3p to up-regulate IREB2 and promote laryngeal squamous cell carcinoma progression.

Hsa_circYARS interacts with miR-29a-3p to up-regulate IREB2 and promote laryngeal squamous cell carcinoma progression.

Journal: Discover oncology

Published: January 10, 2024

Showing 1-12 of 13

Last Updated: 09/26/2026